75F40119F80456↗

Name: 75F40119F80456: Center for Drug Evaluation (Cder) Enterprise Data Architecture for Regulatory Review Support Services
Creator: SpendQuery
License: https://www.usa.gov/government-works

CENTER FOR DRUG EVALUATION (CDER) ENTERPRISE DATA ARCHITECTURE FOR REGULATORY REVIEW SUPPORT SERVICES

Delivery Order · Food and Drug Administration · to Deloitte Consulting LLP (UEI CKV2L9GZKJK3) · data as of 2026-10-22

Obligated to date-$4.2K1 action

Current value$11.80Mwith options exercised

Period2019-09-30 → 2021-12-07current end date

What it is

Product or service: IT and Telecom- Business Continuity (PSC D324)
Industry: Computer Systems Design Services (NAICS 541512)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition · 2 offers received
Pricing: Labor hours
How it was bought: GSA Schedule · under GS35F0617Y
Where the work is: Arlington, VA · district VA-08

Obligations by fiscal year

FY2023-$4.2K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2023-08-14. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2023-08-14	P00008	Close-out	-$4.2K	CENTER FOR DRUG EVALUATION (CDER) ENTERPRISE DATA ARCHITECTURE FOR REGULATORY REVIEW SUPPORT SERVICES

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…